Open AccessEffects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
Author(s) -
Alan Baseman,
Klaus Häger,
Jeffrey S. Nye,
Robert Brashear,
John Han,
Mary Sano,
Bonnie M. Davis,
Henry Richards
Publication year - 2014
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s71540
Subject(s) - medicine , galantamine , placebo , randomized controlled trial , disease , dementia , alternative medicine , donepezil , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom